| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
2,757 |
2,174 |
$380K |
| 87481 |
|
2,104 |
1,662 |
$85K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,372 |
892 |
$59K |
| 87799 |
|
1,675 |
1,377 |
$41K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
1,121 |
900 |
$26K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
709 |
555 |
$24K |
| 87640 |
|
2,425 |
1,902 |
$21K |
| 87653 |
|
1,694 |
1,379 |
$18K |
| 87641 |
|
1,698 |
1,385 |
$18K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,673 |
1,368 |
$17K |
| 87500 |
|
1,502 |
1,248 |
$16K |
| 87493 |
|
743 |
633 |
$10K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
866 |
692 |
$7K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
869 |
691 |
$7K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
797 |
492 |
$6K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
729 |
440 |
$4K |
| 87486 |
|
610 |
446 |
$4K |
| 87541 |
|
609 |
445 |
$3K |
| 87529 |
|
51 |
40 |
$2K |
| 87498 |
|
608 |
445 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
43 |
43 |
$2K |
| 87563 |
|
66 |
53 |
$447.93 |
| 87538 |
|
51 |
40 |
$153.80 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
52 |
42 |
$146.58 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
55 |
43 |
$146.58 |
| 87535 |
|
50 |
40 |
$125.44 |